{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:14:25Z","timestamp":1791134065500,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T00:00:00Z","timestamp":1299974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/nbt.1790","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T19:40:49Z","timestamp":1300045249000},"page":"357-360","source":"Crossref","is-referenced-by-count":81,"title":["Label-free quantification of membrane-ligand interactions using backscattering interferometry"],"prefix":"10.1038","volume":"29","author":[{"given":"Michael M","family":"Baksh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K","family":"Kussrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Mileni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl J","family":"Bornhop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,13]]},"reference":[{"key":"BFnbt1790_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0952-7915(01)00299-0","volume":"14","author":"MF Krummel","year":"2002","unstructured":"Krummel, M.F. & Davis, M.M. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 14, 66\u201374 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnbt1790_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington, J.P., Al-Lazikani, B. & Hopkins, A.L. How many drug targets are there? Nat. Rev. Drug Discov. 5, 993\u2013996 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnbt1790_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1359-6446(01)02131-6","volume":"7","author":"A Wise","year":"2002","unstructured":"Wise, A., Gearing, K. & Rees, S. Target validation of G-protein coupled receptors. Drug Discov. Today 7, 235\u2013246 (2002).","journal-title":"Drug Discov. Today"},{"key":"BFnbt1790_CR4","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1021\/ja047820m","volume":"126","author":"DA Markov","year":"2004","unstructured":"Markov, D.A., Swinney, K. & Bornhop, D.J. Label-free molecular interaction determinations with nanoscale interferometry. J. Am. Chem. Soc. 126, 16659\u201316664 (2004).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnbt1790_CR5","doi-asserted-by":"publisher","first-page":"151108","DOI":"10.1063\/1.2356380","volume":"89","author":"HS Sorensen","year":"2006","unstructured":"Sorensen, H.S., Larsen, N.B., Latham, J.C., Bornhop, D.J. & Andersen, P.E. Highly sensitive biosensing based on interference from light scattering in capillary tubes. Appl. Phys. Lett. 89, 151108 (2006).","journal-title":"Appl. Phys. Lett."},{"key":"BFnbt1790_CR6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1126\/science.1146559","volume":"317","author":"DJ Bornhop","year":"2007","unstructured":"Bornhop, D.J. et al. Free-solution, label-free molecular interactions studied by back-scattering interferometry. Science 317, 1732\u20131736 (2007).","journal-title":"Science"},{"key":"BFnbt1790_CR7","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1021\/ac900569c","volume":"81","author":"A Kussrow","year":"2009","unstructured":"Kussrow, A. et al. Measurement of monovalent and polyvalent carbohydrate-lectin binding by back-scattering interferometry. Anal. Chem. 81, 4889\u20134897 (2009).","journal-title":"Anal. Chem."},{"key":"BFnbt1790_CR8","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino, S., Mauri, L., Chigorno, V. & Prinetti, A. Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R\u201313R (2007).","journal-title":"Glycobiology"},{"key":"BFnbt1790_CR9","first-page":"165","volume":"25","author":"PH Fishman","year":"1993","unstructured":"Fishman, P.H., Pacuszka, T. & Orlandi, P.A. Gangliosides as receptors for bacterial enterotoxins. Adv. Lipid Res. 25, 165\u2013187 (1993).","journal-title":"Adv. Lipid Res."},{"key":"BFnbt1790_CR10","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1021\/bi952314i","volume":"35","author":"GM Kuziemko","year":"1996","unstructured":"Kuziemko, G.M., Stroh, M. & Stevens, R.C. Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry 35, 6375\u20136384 (1996).","journal-title":"Biochemistry"},{"key":"BFnbt1790_CR11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1021\/la026151s","volume":"19","author":"Y Fang","year":"2003","unstructured":"Fang, Y., Frutos, A. & Lahiri, J. Ganglioside microarrays for toxin detection. Langmuir 19, 1500\u20131505 (2003).","journal-title":"Langmuir"},{"key":"BFnbt1790_CR12","doi-asserted-by":"publisher","first-page":"9666","DOI":"10.1021\/la0502645","volume":"21","author":"B Cannon","year":"2005","unstructured":"Cannon, B. et al. Cholesterol modulated antibody binding in supported lipid membranes as determined by total internal reflectance microscopy on a microfabricated high-throughput glass chip. Langmuir 21, 9666\u20139674 (2005).","journal-title":"Langmuir"},{"key":"BFnbt1790_CR13","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1073\/pnas.81.19.6159","volume":"81","author":"AA Brian","year":"1984","unstructured":"Brian, A.A. & McConnell, H.M. Allogenic stimulation of cyto-toxic T-cell by supported planar membranes. Proc. Natl. Acad. Sci. USA 81, 6159\u20136163 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1790_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1126\/science.1119238","volume":"310","author":"KD Mossman","year":"2005","unstructured":"Mossman, K.D., Campi, G., Groves, J.T. & Dustin, M.L. Altered TCR signaling from geometrically repatterned immunological synapses. Science 310, 1191\u20131193 (2005).","journal-title":"Science"},{"key":"BFnbt1790_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1367-5931(03)00079-6","volume":"7","author":"BF Cravatt","year":"2003","unstructured":"Cravatt, B.F. & Lichtman, A.H. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol. 7, 469\u2013475 (2003).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BFnbt1790_CR16","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane, W.A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946\u20131949 (1992).","journal-title":"Science"},{"key":"BFnbt1790_CR17","doi-asserted-by":"publisher","first-page":"10497","DOI":"10.1021\/ja902694n","volume":"131","author":"M Mileni","year":"2009","unstructured":"Mileni, M. et al. Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by \u03b1-ketoheterocycle inhibitors revealed from co-crystal structures. J. Am. Chem. Soc. 131, 10497\u201310506 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnbt1790_CR18","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1021\/jm049614v","volume":"48","author":"DL Boger","year":"2005","unstructured":"Boger, D.L. et al. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J. Med. Chem. 48, 1849\u20131856 (2005).","journal-title":"J. Med. Chem."},{"key":"BFnbt1790_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1021\/jm0611509","volume":"50","author":"FA Romero","year":"2007","unstructured":"Romero, F.A. et al. Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. J. Med. Chem. 50, 1058\u20131068 (2007).","journal-title":"J. Med. Chem."},{"key":"BFnbt1790_CR20","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1021\/jm800136b","volume":"51","author":"J Garfunkle","year":"2008","unstructured":"Garfunkle, J. et al. Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J. Med. Chem. 51, 4392\u20134403 (2008).","journal-title":"J. Med. Chem."},{"key":"BFnbt1790_CR21","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng, Y. & Prusoff, W.H. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099\u20133108 (1973).","journal-title":"Biochem. Pharmacol."},{"key":"BFnbt1790_CR22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.160.2.877","volume":"160","author":"J Hesselgesser","year":"1998","unstructured":"Hesselgesser, J. et al. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J. Immunol. 160, 877\u2013883 (1998).","journal-title":"J. Immunol."},{"key":"BFnbt1790_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.bcp.2004.06.035","volume":"68","author":"J-P Pin","year":"2004","unstructured":"Pin, J.-P. et al. Activation mechanism of the heterodimeric GABAB receptor. Biochem. Pharmacol. 68, 1565\u20131572 (2004).","journal-title":"Biochem. Pharmacol."},{"key":"BFnbt1790_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1124\/mol.60.5.963","volume":"60","author":"S Urwyler","year":"2001","unstructured":"Urwyler, S. et al. Positive allosteric modulation of native and recombinant gamma-aminobutyric acidB receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharm. 60, 963\u2013971 (2001).","journal-title":"Mol. Pharm."},{"key":"BFnbt1790_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0028-3908(85)90075-9","volume":"24","author":"NG Bowery","year":"1985","unstructured":"Bowery, N.G., Hill, D.R. & Hudson, A.L. [3Hl(-)baclofen: an improved ligand for GABAB sites. Neuropharmacology 24, 207\u2013210 (1985).","journal-title":"Neuropharmacology"},{"key":"BFnbt1790_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0960-894X(01)81218-X","volume":"3","author":"W Howson","year":"1993","unstructured":"Howson, W., Mistry, J., Broekman, M. & Hills, J.M. Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABAB agonist with CNS activity. Bioorg. Med. Chem. Lett. 3, 515\u2013518 (1993).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnbt1790_CR27","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/jm00017a015","volume":"38","author":"W Froestl","year":"1995","unstructured":"Froestl, W. et al. Phosphinic acid analogs of GABA. 1. New potent and selective GABAB agonists. J. Med. Chem. 38, 3297\u20133312 (1995).","journal-title":"J. Med. Chem."},{"key":"BFnbt1790_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-2999(93)90836-7","volume":"235","author":"F Brugger","year":"1993","unstructured":"Brugger, F., Wicki, U., Olpe, H.R., Froestl, W. & Mickel, S. The action of new potent GABA-B receptor antagonists in the hemisected spinal cord preparation of the rat. Eur. J. Pharmacol. 235, 153\u2013155 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnbt1790_CR29","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1021\/ac802327h","volume":"81","author":"JC Latham","year":"2009","unstructured":"Latham, J.C., Stein, R.A., Bornhop, D.J. & Mchaourab, H.S. Free-solution label-free detection of \u03b1-crystallin chaperone interactions by back-scattering interferometry. Anal. Chem. 81, 1865\u20131871 (2009).","journal-title":"Anal. Chem."},{"key":"BFnbt1790_CR30","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1084\/jem.20052144","volume":"203","author":"JM Burns","year":"2006","unstructured":"Burns, J.M. et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201\u20132213 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnbt1790_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/386239a0","volume":"386","author":"K Kaupmann","year":"1997","unstructured":"Kaupmann, K. et al. Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature 386, 239\u2013246 (1997).","journal-title":"Nature"},{"key":"BFnbt1790_CR32","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1039\/c0an00098a","volume":"135","author":"AK Kussrow","year":"2010","unstructured":"Kussrow, A.K. et al. The potential of backscattering interferometry as an in vitro clinical diagnostic tool for the serological diagnosis of infectious disease. Analyst (Lond.) 135, 1535\u20131537 (2010).","journal-title":"Analyst (Lond.)"},{"key":"BFnbt1790_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/cbic.201000671","volume":"12","author":"A Kussrow","year":"2011","unstructured":"Kussrow, A., Baksh, M.M., Bornhop, D.J. & Finn, M.G. Universal sensing by transduction of antibody binding using backscattering interferometry. ChemBioChem 12, 367\u2013370 (2011).","journal-title":"ChemBioChem"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.1790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1790","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T18:25:48Z","timestamp":1685989548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.1790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,13]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["BFnbt1790"],"URL":"https:\/\/doi.org\/10.1038\/nbt.1790","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,13]]}}}